Composite setup radar
51
Balanced read
Latest Close
2.57 EUR
12 Jun 2026
1W Return
-4.1%
latest completed week
4W Return
-5.5%
short-term follow-through
12W Return
-
quarterly tape
Trend Breadth
0.0%
0 of 9 weeks active
Volume Ratio
5.0x
vs 13-week average
Company Brief
What the company does
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally. The company's lead product candidates include HDP-101, an anti-BCMA antibody, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It also develops HDP-102, an antibody and the compound Amanitin, which has completed preclinical development for the treatment of non-Hodgkin lymphoma; HDP-103, a proprietary ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for the treatment of gastrointestinal tumors; HDP-201 for the treatment of colorectal cancer; …
Snapshot
What the weekly tape is saying
HPHA closed the latest completed week at 2.57 EUR. The 4-week return is -5.5% and the 12-week return is -. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Balanced read with a 51/100 composite read.
Trend Signal
Inactive
Market Dynamics
No fresh buy
Price vs Trend
-
Volume
5.0x
Setup Cockpit
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
Trend
0
Persistence of active Trend Signal over the last year and current streak.
Momentum
37
Blend of 4-week and 12-week follow-through.
Dynamics
50
Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength
50
Relative leadership and short-term RS change.
Volume
100
Participation compared with the 13-week volume baseline.
Risk Control
71
Drawdown and recent weekly volatility pressure.
16-week signal tape
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
Weekly return bar
Trend Signal dot
Positive Market Dynamics dot
Price Action
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price
Trend Line
Fair Value
Price map
- Trend Line
- -
- Vs Trend Line
- -
- Fair Value
- 2.72 EUR
- Vs Fair Value
- -5.6%
- 52W High
- 2.84 EUR
- 52W Low
- 2.52 EUR
- Drawdown
- -9.5%
- Range Position
- 15.6%
Momentum
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- AT Healthcare
- Sector Rank
- 93 of 112
- Sector Percentile
- 17.1%
Peer Context
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Biotechnology
- Tracked Peers
- 21
- 4W Rank
- 15 of 21
- Avg 1W
- -2.5%
- Avg 4W
- 0.3%
- Trend Breadth
- 23.8%
- Positive RS
- 9.5%
Market Dynamics
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Market Dynamics
Relative Strength
Signal state
- Market Dynamics
- 0.00
- 4W MD Change
- -
- Relative Strength
- -
- 4W RS Change
- -
- Expectation
- Undecided
- Probability
- 46.41%
Volume
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 25
- 13W Average
- 5
- 52W Average
- 5
- Vs 13W
- 5.0x
- Vs 52W
- 5.0x
Risk Anatomy
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 1.9%
- 52W Volatility
- 1.9%
- Upside Weeks
- 3
- Downside Weeks
- 5
- Downside Breadth
- 62.5%
- Avg Gain / Loss
- 1.3% / -2.1%
Context
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 126.8M
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.57 EUR | -4.1% | - | 2.72 EUR | 0.00 | - | 25 | Off |
| 5 Jun 2026 | 2.68 EUR | -1.1% | - | 2.74 EUR | 0.00 | - | 0 | Off |
| 29 May 2026 | 2.71 EUR | -2.2% | - | 2.75 EUR | 0.00 | - | 0 | Off |
| 22 May 2026 | 2.77 EUR | 1.8% | - | 2.76 EUR | 0.00 | - | 0 | Off |
| 15 May 2026 | 2.72 EUR | -2.5% | - | 2.76 EUR | 0.00 | - | 0 | Off |
| 8 May 2026 | 2.79 EUR | 1.5% | - | 2.77 EUR | 0.00 | - | 0 | Off |
| 1 May 2026 | 2.75 EUR | -0.7% | - | 2.76 EUR | - | - | 20 | Off |
| 24 Apr 2026 | 2.77 EUR | 0.7% | - | 2.76 EUR | - | - | 0 | Off |
| 17 Apr 2026 | 2.75 EUR | - | - | 2.75 EUR | - | - | 0 | Off |